Disrupting HTR6-neurofibromin interaction prevents agonist-independent HTR6-operated cAMP signaling in the prefrontal cortex, an effect that might underlie neuronal abnormalities in NF1 patients [9]. Here, NF1 is linked to neurofibromatosis type 1.